Workflow
MONDAY DEADLINE: Berger Montague Advises Hims & Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Class Action by August 25, 2025
HimsHims(US:HIMS) GlobeNewswire News Roomยท2025-08-22 15:17

Core Viewpoint - Berger Montague is investigating potential securities fraud claims against Hims & Hers Health Inc. following the termination of its partnership with Novo Nordisk due to allegations of deceptive marketing and regulatory non-compliance [1][3][4]. Group 1: Legal Investigation - Investors who acquired Hims & Hers securities between April 29, 2025, and June 22, 2025, have until August 25, 2025, to seek appointment as lead plaintiff representative [2]. - The lawsuit claims that Hims & Hers made materially false or misleading statements regarding its GLP-1 offerings and the partnership with Novo Nordisk [4]. Group 2: Market Reaction - Following the announcement of the partnership termination, Hims & Hers shares fell by over 34% in intraday trading, indicating significant investor concern over regulatory compliance and reputational risks [3].